Bredel et al. (Bredel et al., 2011) showed that NFKBIA (nuclear factor of κ-light polypeptide gene enhancer in B-cells inhibitor-α) deletion and EGFR amplification have a similar effect in the pathogenicity of GBM, but their effect is exclusive. The gene discussed is NFKBIA; the disease is glioblastoma.